Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 2485 for “"Malignancies"”.

  1. Rheumatic diseases and malignancies /

    … aims to present different mechanisms of malignancies as a comorbidity in rheumatic diseases and mechanisms of the development of rheumatic syndromes in cancer patients. Cancer poses a major threat to public health worldwide and is one of the leading causes of death with increasing …

    vilnius Repository record for Rheumatic diseases and malignancies / (opens in a new tab)

  2. Trisomies in Hematologic Malignancies

    … leukemogenesis, are found in many hematologic malignancies. Although the balanced rearrangements, such as translocations and inversions, are the ones most commonly thought of in the context of leukemias, gains of chromosomes ? e.g.., trisomies ? are also frequent. Little is known about the …

    lund Repository record for Trisomies in Hematologic Malignancies (opens in a new tab) Download PDF for Trisomies in Hematologic Malignancies (opens in a new tab)

  3. IMMUNOTHERAPY FOR T CELL MALIGNANCIES

    … survival in patients with solid and hematologic malignancies. However, adults with T cell leukemias and lymphomas, collectively called T cell cancers, still face short survival and lack effective targeted therapies. Unlike treatment for B cell malignancies, where total B cell depletion is …

    jhu Repository record for IMMUNOTHERAPY FOR T CELL MALIGNANCIES (opens in a new tab) Embargoed until 2027-05-01

  4. TARGETED THERAPY FOR UROLOGIC MALIGNANCIES

    We determined the predictive value of NRAMP1 and hGPX1 gene polymorphisms for cancer recurrence and response to intravesical Bacillus Calmette-Guerin (BCG) immunotherapy in non-muscle-invasive bladder cancer (BC) patients, by performing single nucleotide polymorphisms analysis of their peripheral …

    nus Repository record for TARGETED THERAPY FOR UROLOGIC MALIGNANCIES (opens in a new tab) Download file for TARGETED THERAPY FOR UROLOGIC MALIGNANCIES (opens in a new tab)

  5. Genetic profiling of haematological malignancies

    <p>Acute lymphoblastic leukaemia (ALL) accounts for approximately 3% of all cancers, and leads to more than 4250 deaths a year. The different classes of leukaemia comprise numerous heterogeneous subgroups, which differ in their cellular and molecular characteristics, as well as their response to …

    soton Download PDF for Genetic profiling of haematological malignancies (opens in a new tab)

  6. Novel Therapeutics for Myeloid Malignancies

    Myeloid malignancies are a group of heterogenous and clonal disorders that include myeloproliferative neoplasms (MPNs) and acute myeloid leukemia (AML). These blood cancers are driven by characteristic oncogenes and propagated by pro-inflammatory niches; MPNs demonstrate hyperactive JAK-STAT …

    wustl Repository record for Novel Therapeutics for Myeloid Malignancies (opens in a new tab)

  7. GERMLINE & SOMATIC VARIATION IN GASTROINTESTINAL MALIGNANCIES

    Germline Somatic Variation in Gastrointestinal Malignancies Ashton Antoine Connor Doctor of Philosophy Institute of Medical Science (IMS) University of Toronto 2017 Abstract Primary gastrointestinal malignancies have among the highest incidence, morbidity and mortality rates. We hypothesized that …

    toronto-retro Repository record for GERMLINE & SOMATIC VARIATION IN GASTROINTESTINAL MALIGNANCIES (opens in a new tab)

  8. Hypoxia regulated pathways in urological malignancies

    Introduction: Kidney Cancer accounts for approximately 2% of all new cancer diagnoses in<br/>the UK each year. Patient survival has improved over the past few decades; however the<br/>mechanisms of this are yet to be fully elucidated. Hypoxia inducible factor isoforms, HIF-1 and<br/>HIF-2, are …

    soton Download PDF for Hypoxia regulated pathways in urological malignancies (opens in a new tab)

  9. Immunotherapy and immunomodulation for haematological malignancies

    … strategies in patients with haematological malignancies.</p>

    oxford Repository record for Immunotherapy and immunomodulation for haematological malignancies (opens in a new tab)

  10. Role of STAG2 in Myeloid Malignancies

    … consequences of cohesin mutations in myeloid malignancies. This led to the identification of mutations in three components of cohesin ring in 6% (9/154) of the patients with maximum number of mutations identified in STAG2. None of the patients with cohesin aberrations had a TP53 mutation and …

    kings Repository record for Role of STAG2 in Myeloid Malignancies (opens in a new tab) Download PDF for Role of STAG2 in Myeloid Malignancies (opens in a new tab)

  11. The risk of developing subsequent primary malignancies among adult patients with lymphatic and haematopoietic malignancies in Germany

    … The increased risk of subsequent primary malignancies (SPM) in survivors of adult lymphohaematopoietic malignancies (LHM) remains a challenging clinical problem worldwide. In Germany, no national estimates exist until now for this risk. Based on the recently pooled German cancer registry …

    fu-berlin Repository record for The risk of developing subsequent primary malignancies among adult patients with lymphatic and haematopoietic malignancies in Germany (opens in a new tab)

  12. Impact of the Microbiome on Female Malignancies

    Background: Cervical cancer is the fourth most common cancer, while breast cancer is the most common cancer diagnosed in women globally. Many factors influence the development of both cancers. We focused on gut microbial dysbiosis in HPV-positive cervical cancer due to the limited amount of …

    jhu Repository record for Impact of the Microbiome on Female Malignancies (opens in a new tab) Embargoed until 2029-05-01

  13. Immunogenetic analysis of aggressive B-cell malignancies

    … in every cell of the tumour clone. Since B-cell malignancies typically have functional Ig gene rearrangements and express surface Ig, analysis of the Ig V genes can provide an independent marker for a clonal B-cell population and may help to establish the developmental stage at which neoplastic …

    soton Download PDF for Immunogenetic analysis of aggressive B-cell malignancies (opens in a new tab)

  14. Critical Illness in Patients with Hematologic Malignancies

    … and symptoms for patients with hematologic malignancies who survive an ICU admission. Objectives: This thesis 1) characterizes the epidemiology of critical illness after a new diagnosis of hematologic malignancy in a large population-based cohort in Ontario, Canada; 2) evaluates the …

    toronto-retro Repository record for Critical Illness in Patients with Hematologic Malignancies (opens in a new tab)

  15. The role of hypoxia in urological malignancies

    <p>Hypoxia, a state of low oxygen, is a feature of most solid tumours as a consequence of poor tumour vascularisation. The mechanisms, which allow cancer cells to survive and continue to grow in hypoxia, are coordinated by the transcription factor HIF. The tumour suppressor gene von Hippel-Lindau …

    oxford Repository record for The role of hypoxia in urological malignancies (opens in a new tab)

Page 1 of 125